FTC Investigates Valeant's Dermatology Buys
The exact nature of the FTC's antitrust concerns was not immediately clear, but the company said in a statement that it still expected both deals to close before the end of the year.
The requests delay, at least temporarily, the Ontario-based company's July pickups of two dermatology units that would...
Already a subscriber? Click here to login